Washington University

Christopher Nelson

Daved Henry Fremont

Steven Teitelbaum

Julia T Warren

Guy M Houser

Michael S Diamond

David L Walter

Larissa Thackray

Derek Platt

Haiyan Zhao

Estefania Fernandez

Arthur Kim

Katherine Basore

Rong Zhang

Joel Schneider Lippold

Geoffrey Michael Wod

Among the various aspects of the present disclosure is the provision of compositions and methods of treating arthritogenic alphavirus infection and methods of screening.

Compositions and methods for inhibition of alphavirus infection

A portable net system for net games is disclosed which provides for rapid assembly, lightweight construction, durability against damage while assembling and playing, and also provides enhancements inherent in the design which allow for improved marketing and advertising during tournaments. The net functions through having a bow-shaped tensioning rod reacting against the net top-tape to provide primary shape, net tension and height control. A vertical post at each distal end is attached to the foldable feet to provide lateral stability, and these are attached to the net via insertion into the net end-band and durably connected via the rigid bow end-connectors. Removable end-panels at each end net termination provides for a self-tensioned surface where advertising and sponsor labels may be attached.

Collapsible devices for improving playability and marketability of net based sports

The present disclosure relates to antibodies specific to Zika virus and methods for detecting Zika virus infection in a subject. The present disclosure also relates to therapeutic antibodies useful in reducing viral load.

Antibodies to zika virus and methods of use thereof

Methods for constructing efficient inhibitors of target TNF superfamily receptors, single chain target TNF superfamily ligands that inhibit of target TNF superfamily receptors while failing to engage or inhibit non-target TNF superfamily receptors, and methods of their use to treat diseases are provided. Single chain RANKL, TNF, and TRAIL ligands that effectively inhibit their target receptors while failing to inhibit non-target TNF superfamily receptors are also provided.

Mutant tumor necrosis factor receptor superfamily (TNFsfR) ligands and methods of making and using same

Oligomers for TNF superfamily inhibition, methods of making and using

Oligomers for TNF superfamily inhibition

Growing community of inventors

St. Louis, MO, United States of America

Christopher Nelson